Current advances in ACE inhibition 3 : proceedings of an International Symposium RAI Congress Centre, Amsterdam, The Netherlands, 19-23 March, 1993
著者
書誌事項
Current advances in ACE inhibition 3 : proceedings of an International Symposium RAI Congress Centre, Amsterdam, The Netherlands, 19-23 March, 1993
Churchill Livingstone, 1993
大学図書館所蔵 件 / 全1件
-
該当する所蔵館はありません
- すべての絞り込み条件を解除する
内容説明・目次
内容説明
Contains the proceedings of the Third International Symposium on ACE Inhibition (Amsterdam 19-23 March 1993). This book represents an update on issues relating to ACE inhibition. It also provides information relating to current research and developments in the field.
目次
- THE VASCULATURE: Hypertensive vascular disease - pathophysiological mechanisms
- The role of angiotensin II and other growth factors in vascular hypertrophy
- Vascular remodelling: a role for ACE inhibitors?. THE HEART: From hypertension to hypertrophy - molecular and cellular mechanisms
- The renin-angiotensin system, the heart and the genesis of arrhythmias
- What is the mechanism by which ACE inhibitors reduce mortality in heart failure?
- Left ventrical structural remodelling - potential for therapeutic intervention
- Is the ACE insertion/deletion polymorphism a risk factor for myocardial infarction? THE KIDNEY: Intrarenal actions of angiotensin II: role in health and disease
- Inhibition of renin-angiotensin system and its effects on renal function - experimental evidence
- Do ACE inhibitors preserve renal function in man?
- The role of ACE inhibitors in patients with renal disease
- Renovascular hypertension - the role of ACE inhibitors. CLINICAL PHARMACOLOGY: Differences between ACE inhibitors - are any of clinical relevance?
- ACE inhibitors - concentration effect, dose response and duration of action in man
- Indications for ACE inhibitors in the treatment of hypertension. OTHER INHIBITORS OF THE RENIN SYSTEM: Molecular and regulatory aspects of ACE - new developments
- Localisation of angiotensin II receptors in various tissues
- Differences between angiotensin II antagonists
- Clinical evaluation of AII antagonists in hypertension
- Renin inhibitors
- Renin-angiotensin system inhibition: which intervention site should be targeted?. GENERAL: Diabetes - long-term renal protection - specific benefits from ACE inhibitors
- Long-term renal protection - specific benefits from ACE inhibitors - the case for and against
- Future use of ACE inhibitors.
「Nielsen BookData」 より
